UNICHEM LABS LTD
GenericsUNICHEM LABS LTD is a generic drug manufacturer focused on Cardiovascular, Neurology, Gastroenterology.
UNICHEM LABS LTD's Key Drugs
UNICHEM LABS LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
UNICHEM LABS LTD's Recent FDA Approvals
UNICHEM LABS LTD secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
UNICHEM LABS LTD's Therapeutic Areas
UNICHEM LABS LTD's approved drugs and pipeline span 4 therapeutic areas, led by Cardiovascular and Neurology, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
UNICHEM LABS LTD's Top Competitors
UNICHEM LABS LTD's closest competitors by therapeutic-area and drug-target overlap include WARNER CHILCOTT, Bristol-Myers Squibb, and BAUSCH. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
UNICHEM LABS LTD Pipeline Snapshot
Active clinical trials for UNICHEM LABS LTD across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2006-12-20
- Latest
- 2026-06-18
- Applications
- 75